Initial experience with contrast-enhanced sonography of the prostate

被引:68
作者
Halpern, EJ
Verkh, L
Forsberg, F
Gomella, LG
Mattrey, RF
Goldberg, BB
机构
[1] Thomas Jefferson Univ, Dept Radiol, Jefferson Prostate Ctr, Philadelphia, PA 19107 USA
[2] Alliance Pharmaceut Corp, San Diego, CA 92121 USA
[3] Thomas Jefferson Univ, Jefferson Prostate Ctr, Dept Urol, Philadelphia, PA 19107 USA
[4] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA
关键词
D O I
10.2214/ajr.174.6.1741575
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
OBJECTIVE. We investigated the usefulness of contrast-enhanced sonography to depict vascularity in the prostate and improve the detection of prostatic cancer. SUBJECTS AND METHODS. Twenty-six patients with an elevated prostate-specific antigen level (greater than or equal to 4 ng/ml) or an abnormal digital rectal examination were enrolled in a phase II study of an IV injected sonographic contrast agent, Continuous gray-scale, intermittent gray scale, phase inversion gray-scale, and power Doppler sonography of the prostate were performed. Sonographic findings were correlated with sextant biopsy results. RESULTS. After the administration of contrast material, gray-scale and Doppler images revealed visible enhancement (p < 0.05). Using intermittent imaging, we found focal enhancement in two isoechoic rumors that were not visible on baseline images. No definite focal area of enhancement was identified in any patient without cancer. Contrast-enhanced images revealed transient hemorrhage in the biopsy tracts of three patients. CONCLUSION. Enhancement of the prostate can be seen on gray-scale and Doppler sonographic images after the administration of an IV contrast agent, Contrast-enhanced intermittent sonography of the prostate may be useful for the selective enhancement of malignant prostatic tissue.
引用
收藏
页码:1575 / 1580
页数:6
相关论文
共 29 条
[1]
Transrectal ultrasound of the prostate: Innovations and future applications [J].
Aarnink, RG ;
Beerlage, HP ;
De la Rosette, JJMCH ;
Debruyne, FMJ ;
Wijkstra, H .
JOURNAL OF UROLOGY, 1998, 159 (05) :1568-1579
[2]
Blomley MJ, 1997, RADIOLOGY, V205, P280
[3]
Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting [J].
Borre, M ;
Offersen, BV ;
Nerstrom, B ;
Overgaard, J .
BRITISH JOURNAL OF CANCER, 1998, 78 (07) :940-944
[4]
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies [J].
Bostwick, DG ;
Wheeler, TM ;
Blute, M ;
Barrett, DM ;
MacLennan, GT ;
Sebo, TJ ;
Scardino, PT ;
Humphrey, PA ;
Hudson, MA ;
Fradet, Y ;
Miller, GJ ;
Crawford, ED ;
Blumenstein, BA ;
Mahran, HE ;
Miles, BJ .
UROLOGY, 1996, 48 (01) :47-57
[5]
BRAWER MK, 1994, CANCER, V73, P678, DOI 10.1002/1097-0142(19940201)73:3<678::AID-CNCR2820730329>3.0.CO
[6]
2-6
[7]
Brawer MK, 1996, CANCER, V78, P345, DOI 10.1002/(SICI)1097-0142(19960715)78:2<345::AID-CNCR25>3.0.CO
[8]
2-V
[9]
Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent [J].
Broillet, A ;
Puginier, J ;
Ventrone, R ;
Schneider, M .
INVESTIGATIVE RADIOLOGY, 1998, 33 (04) :209-215
[10]
Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging [J].
Colon, PJ ;
Richards, DR ;
Moreno, CA ;
Murgo, JP ;
Cheirif, J .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 1997, 10 (06) :602-607